Richard Manning

Dr. Richard Manning is a Managing Director at Intensity. He provides economic and data-driven insights to help clients solve complex problems arising in a variety of business settings with emphasis on life sciences, including innovative and follow-on biopharmaceuticals in both prescription and Over the Counter (OTC) settings, medical devices, and animal health. His areas of expertise include:

• Economic Valuation and Damages
• Intellectual Property
• Breach of Contract, Fraud, and other Commercial Litigation
• Transaction and Securities Litigation
• Tax, Antitrust, and Competition
• Public Policy

Dr. Manning has testified in U.S. District Court, U.S. Bankruptcy Court, the Delaware Court of Chancery, that the United States Patent Trial and Appeals Board, and the International Chamber of Commerce; served as consulting expert and prepared reports and commentary on a wide range of issues in the biopharmaceutical (both innovative and follow-on sectors) and healthcare industries. His career includes 14 years as an executive in multinational pharmaceutical companies where he led economic analysis and strategy development to shape practices related to emerging business concerns.

Examples of Dr. Manning’s work include:

| Economic analysis and strategy relative to challenges affecting pricing, reimbursement, marketing, manufacturing, R&D investments, and intellectual property protection, including commercial success, Paragraph IV and reverse settlements.

| Economic valuation of early-stage companies and strategic investments; evaluating merger and acquisitions; industry profitability and other financial analyses.

| Analyzing healthcare benefit design; healthcare system reforms; FDA regulatory reform, including biosimilars review processes and product safety.

Prior to joining Intensity, Dr. Manning was a Partner at Bates White, an economic consulting firm offering analysis and expert testimony services to law firms, Fortune 500 companies, and government agencies. Previously, Dr. Manning was Executive Director at Merck & Co., Inc., and he was Senior Director at Pfizer, Inc. Dr. Manning was also a Director in the Advisory Strategy Group at PricewaterhouseCoopers.

Dr. Manning was an economics professor at Brigham Young University and a visiting professor in the Graduate School of Business at the University of Chicago. As an academic, his teaching and research focused on price theory, the economic analysis of law, industrial organization, and the economics of government regulation.

Dr. Manning received his Ph.D. in Economics from the University of Chicago. He earned his B.A. in Economics from Brigham Young University.